QoL and the Emotional-affective Sphere in Rehabilitation Setting During COVID-19 Quarantine

March 29, 2022 updated by: Irene Giovanna Aprile, Fondazione Don Carlo Gnocchi Onlus

Effects of Social Distancing on the Quality of Life and on the Emotional-affective Sphere of Caregivers and Patients Hospitalized in Residential Rehabilitation Departments: an Observational Study.

Coronavirus disease (COVID-19) is caused by the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) virus. This virus was identified in December 2019 in the Chinese city of Wuhan, in the province of Hubei, where it determined a state of health emergency proclaimed by China on January 30, 2020.

Since February 2020, Italy has been involved in the emergency of the COVID-19 infection, with devastating consequences for the health of the population and the economy of our country. As published by the Italian National Institute of Health, the starting date of the symptoms dates back to the end of January, the first case diagnosed dates back to 21 February 2020 while the first cases of home isolation date back to March 1st, 2020. On March 30, 2020, there were 101739 positive subjects and 11591 deaths (Civil Protection data).

According to data published by the World Health Organization, most people with COVID-19 develop a flu-like form, 14% develop a severe form that requires hospitalization and oxygen therapy and 5% require an ICU admission.

The emergency from Covid19 made it necessary to provide institutional social distancing conditions which resulted in rehabilitation departments being prohibited from visiting patients by family members and/or caregivers. This event, although necessary, led to the first moment of discomfort on the part of patients and family members; to overcome this reaction "technological" solutions were found, trying to give continuity to the contact between the patient and the family member through the use of video calls. Despite this, the COVID-19 emergency and the limitations resulting from social distancing likely have an impact on both patients and family members/caregivers that needs to be assessed.

Study Overview

Status

Completed

Conditions

Detailed Description

Aims:

The study aims to measure the quality of life (QoL) and the emotional-affective sphere of patients, currently hospitalized in residential structures, and their family members.

The study data will allow identifying (a) whether the social distancing between family members/caregivers and patients undergoing rehabilitation for orthopedic or neurological disabilities affects the quality of life and the emotional-affective sphere and (b) if these conditions change over time. The data obtained will, therefore, allow identifying those subjects who present a particular fragility of the emotional-affective sphere and who therefore need attention and possibly psychological support that will be prescribed.

Procedures:

Demographic (for patients and caregivers) and anamnestic (only for patients) data will be collected; moreover, disability will be assessed in patients using the modified Barthel index.

Three questionnaires will be administered to patients and caregivers:

  • The Short Form (36) Health Survey (SF36), to evaluate the QoL;
  • The Beck Anxiety Inventory (BAI), to evaluate the emotional state;
  • The Beck Depression Inventory-II (BDI-II), to evaluate mood.

These questionnaires will be administered after one month of hospitalization (T0), and after one (T1) and two (T2) months after T0. Finally, at time T1 and T2 it will be registered if the patient is still hospitalized or discharged (and in the latter case the days between the discharge and the compilation of the questionnaire will be recorded). Since the three selected questionnaires provide for self-administration, to simplify the collection of data relating to caregivers, the implementation and use of an online questionnaire will be assessed. This questionnaire will also provide for the collection of consent to the use of data by the subject and will guarantee their privacy.

Study Type

Observational

Enrollment (Actual)

121

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rome, Italy, 00168
        • Don Gnocchi Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients admitted to inpatients rehabilitation centers

Caregivers of patients admitted to inpatients rehabilitation centers

Description

Inclusion Criteria:

  • patients admitted to the centers of the Don Gnocchi Foundation participating in the study and their caregivers will be recruited

Exclusion Criteria:

  • For patients: a score on the Mini-Mental State Examination (MMSE) scale lower than 24 which prevents the administration of SF36;
  • For patients and caregivers: failure to acquire informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Patients
100 patients admitted to an inpatient rehabilitation facility
Caregivers
100 caregivers of patients admitted to an inpatient rehabilitation facility

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Form-36 Health Survey (SF36)
Time Frame: After one month of hospitalisation (baseline, T0)
It is a questionnaire to evaluate the Quality of Life
After one month of hospitalisation (baseline, T0)
Short Form (36) Health Survey (SF36)
Time Frame: One month after baseline (T1)
It is a questionnaire to evaluate the Quality of Life
One month after baseline (T1)
Short Form (36) Health Survey (SF36)
Time Frame: Two months after baseline (T2)
It is a questionnaire to evaluate the Quality of Life
Two months after baseline (T2)
Beck Anxiety Inventory (BAI)
Time Frame: After one month of hospitalisation (baseline,T0)
It is a brief, criteria-referenced assessment for measuring anxiety severity and level
After one month of hospitalisation (baseline,T0)
Beck Anxiety Inventory (BAI)
Time Frame: One month after baseline (T1)
It is a brief, criteria-referenced assessment for measuring anxiety severity and level
One month after baseline (T1)
Beck Anxiety Inventory (BAI)
Time Frame: Two months after baseline (T2)
It is a brief, criteria-referenced assessment for measuring anxiety severity and level
Two months after baseline (T2)
Beck Depression Inventory-II (BDI-II)
Time Frame: After one month of hospitalisation (baseline)
It is a brief, criteria-referenced assessment for measuring depression severity
After one month of hospitalisation (baseline)
Beck Depression Inventory-II (BDI-II)
Time Frame: One month after baseline (T1)
It is a brief, criteria-referenced assessment for measuring depression severity
One month after baseline (T1)
Beck Depression Inventory-II (BDI-II)
Time Frame: Two months after baseline (T2)
It is a brief, criteria-referenced assessment for measuring depression severity
Two months after baseline (T2)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
modified Barthel Index (mBI)
Time Frame: After one month of hospitalisation (baseline, T0)
It is a measure of physical disability used widely to assess behaviour relating to activities of daily living for stroke patients or patients with other disabling conditions.
After one month of hospitalisation (baseline, T0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Irene APRILE, MD,PHD, IRCCS Fondazione Don Carlo Gnocchi

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 26, 2020

Primary Completion (Actual)

February 15, 2021

Study Completion (Actual)

February 22, 2021

Study Registration Dates

First Submitted

May 21, 2020

First Submitted That Met QC Criteria

May 27, 2020

First Posted (Actual)

May 29, 2020

Study Record Updates

Last Update Posted (Actual)

April 7, 2022

Last Update Submitted That Met QC Criteria

March 29, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • FDG_socialdistancing_COVID-19

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

3
Subscribe